Page 30 - BIPAR Annual Report 2020_EN short
P. 30

EU Regulation on



                                                                                                                                                                                   KID for PRIIPs









          is particularly challenging until there is further clarity of the trading landscape post-Brexit.                         Subject matter and scope                                          Background

          ESMA started working on the review reports under MiFID II, amongst others with a call for evidence on the disclosure of   The Regulation applies to packaged retail and insurance-based investment
          inducements, costs and charges published in July 2019, to which BIPAR responded. Early April 2020, ESMA published its    products, which are, broadly speaking, products where the amount repayable,   The PRIIPs EU Regulation introduces
          report containing technical advice to the Commission. In the advice, ESMA does not call for a complete ban on induce-    or the maturity or surrender value, is subject to fluctuations. It does not apply   a standardised, easy to understand,
          ments under MiFID II. It does call on the Commission to assess the impact the MiFID II inducements regime has had on     to non-life insurance or to life insurance contracts where the benefits under   precontractual “Key Information
          the distribution of retail investment products across the Union, the effects a ban on inducements would have on the      the contract are payable only on death or incapacity due to injury, sickness
          different distribution models existing in the Union and what actions that could be taken to mitigate the risk of undesired   or  infirmity.  It  does  not  apply  to  “simple”  deposits,  certain  securities  and   Document (KID)” for PRIIPs, which
          consequences of an  inducements ban.                                                                                     pensions  (for  pensions,  the  Commission should  assess the  situation  in  its   should facilitate comparison between
                                                                                                                                   review).                                                          different products. The Regulation has
          ESMA added that to assess the potential positive or negative effects of a ban, “the impact of the bans as introduced in
          the Netherlands and the United Kingdom should be examined” and that such impact assessment be carried out and any        The Regulation only aims at the protection of retail investors (i.e. “client” as   applied since January 2018, is binding
          following actions be taken in relation to all retail investment products, not just MiFID financial instruments. ESMA also   defined in MiFID II or “customer” as defined in IMD I where that customer   in its entirety and directly applicable in
          suggests considering additional actions to also tackle investor protection issues arising in “closed-distribution models”.  would not qualify as a professional client as defined in MiFID II).  all Member States.


          Regarding the MiFID II costs and charges disclosure regime, ESMA also stated that investment products with the same      Key issues for intermediaries/financial advisers
          characteristics should be treated the same.
                                                                                                                                   BIPAR agreed, from the outset, that for all products which include an investment risk, specific, proportional and relevant
          The Commission launched its public consultation on the review of MiFID II in February 2020. The consultation asks        pre-contractual information should be available. BIPAR requested clear confirmation about who is responsible for the
          amongst others if there should be an outright ban on inducements and looks at the existing rules such as on Product      KID. Throughout the legislative process BIPAR opposed any additions to the KID regarding information on the person
          Oversight and Governance. Taking into account the Covid-19 crisis, BIPAR asked for an extension of the deadline to       selling the product, which is already adequately addressed in specific instruments, such as MiFID and IDD.  Since the
          respond, which was accepted. BIPAR stated it believes the current MiFID II framework lacks proportionality for small     application, BIPAR discussed with its members the availability and use of KIDs in practice, for example, on risk rating and
          financial intermediaries or advisers. Certain targeted improvements to the MiFID II regulatory framework would be wel-   the risk scales used, on the costs/pricing scenario for the basis of the KID, on performance scenarios and on the specific
          come, but always after profound stakeholder discussion and considering the Covid-19 related situation. BIPAR recalled    case of UCITs (Undertakings for the Collective Investment in Transferable Securities - see below).
          that the current system offers transparent choice for investors between different advice models in a strictly regulated
          and supervised system.








































                                                            30                                                                                                                     31
   25   26   27   28   29   30   31   32   33   34   35